Dealroom – Growth Equity Healthtech MTIP, 2024

The global healthcare sector is experiencing significant growth, with healthcare spending reaching $10 trillion in 2022. The rise in costs is driven by factors such as increasing disease burden, an aging population, and clinical workforce shortages. The need for new business models and technological innovation in healthcare is becoming crucial, with digitalization of care playing a key role in improving efficiency and outcomes. Healthtech startups are seeing rapid growth, with sub-sectors like digital care and health IT experiencing significant momentum. Despite a drop in growth stage financing in 2023, the outlook for 2024 looks promising, with investments expected to rise driven by advancements in AI, telemedicine, and personalized healthcare technologies. MTIP and Dealroom are exploring the investment landscape of growth-stage healthtech companies in Europe, focusing on startups that leverage technology to optimize healthcare delivery and make it more accessible. The report will cover startups at the Series A to C stage, highlighting key trends and opportunities in the healthtech sector.